Symbol Surfing makes it fast & easy to find your next great idea. Just select a channel to get started.
The 52 Week Low is $446.38 set on Wed, Mar 3, 2021. The current price, $651.88, is 46% above the 52 Week Low.
The 52 Week High is $686.28 set on Wed, Sep 1, 2021.
The All-Time High is $686.28 set on Wed, Sep 1, 2021.
Regeneron Pharmaceuticals trades on the NASDAQ. REGN's market cap is 69.7 Billion.
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products including: Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in atopic dermatitis, asthma, and nasal polyposis; Libtayo in cutaneous squamous cell carcinoma; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer, and bispecific antibodies and antibody cocktails with other collaborators and independently.